4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow Cervical Neoplasm: new trials by email Literature Review of Cervical Neoplasm trials Research Report on Cervical Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection. Topical ABI-1968 - HSIL of Cervix, HSIL, High Grade Squamous Intraepithelial Lesions | Phase 1 | Completed | Antiva Biosciences | 8 | 2018-12-21 | 2021-01-13 |
| Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection ABI-1968 - HSIL, HSIL of Cervix | Phase 1 | Completed | Antiva Biosciences | 16 | 2018-01-01 | 2019-07-10 |
| HARE-40: HPV Anti-CD40 RNA vaccinE BNT113 - Human Papilloma Virus Related Carcinoma, Head and Neck Neoplasm | Phase 1 / Phase 2 | Completed | University of Southampton | 30 | 2017-04-11 | 2026-10-07 |
| The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru Gardasil - Cervical Intraepithelial Neoplasia, Cervical Cancer | Phase 1 | Completed | Preventive Oncology International, Inc. | 642 | 2011-05-01 | 2014-04-21 |
Uterine Cervical Neoplasms (4) · Uterine Cervical Dysplasia (3) · Squamous Intraepithelial Lesions (2) · Head and Neck Neoplasms (1) · Neoplasms, Unknown Primary (1) · Penile Neoplasms (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Neoplasms (4) · Neoplasms by Site (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Uterine Cervical Diseases (4) · Uterine Diseases (4) · Uterine Neoplasms (4) · Pathological Conditions, Signs and Symptoms (3) · Precancerous Conditions (3) · Morphological and Microscopic Findings (2)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)
Antiva Biosciences (2) · Preventive Oncology International, Inc. (1) · University of Southampton (1)
Australia (1) · Peru (1) · South Africa (1) · United Kingdom (1) · United States (1)
Carlos Vallejos Sologuren, MD (1) · Christian Ottensmeier, Prof (1) · Ioannis Karydis, Dr (1) · Jerome L Belinson, MD (1)
2014 (1)